Skip to content

Venlafaxine versus Citalopram in treatment of depression

Venlafaxine versus Citalopram in treatment of acute phase of major depression disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201203048513N1
Enrollment
53
Registered
2014-07-09
Start date
2012-04-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder. Mild depressive episode , Moderate depressive episode

Interventions

Intervention 1: average 25 patients are randomized in this group.citalopram is commenced with the initial dose of 10 mg daily, and gradually increases to 40 mg daily.this study lasts 8 weeks and we co
Treatment - Drugs
average 25 patients are randomized in this group.citalopram is commenced with the initial dose of 10 mg daily, and gradually increases to 40 mg daily.this study lasts 8 weeks and we collect patients i
average 25 patients are randomized in this group.venlafaxine starting dose is 37.5 mg daily , then gradually increases to 150 mg daily.this study lasts 8 weeks and we collect patients information incl

Sponsors

Shahid Sadughi University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 54 Years

Inclusion criteria

Inclusion criteria: inclusion criteria :mild to moderate major depressive disorder ; patients with primary depression or with any symptom in a month ago exclusion criteria : severe depression ;bipolarity ; anxiety disorder ; alcoholic or drug abuse ; patients with other significant medical diseases ; psychotic disorder ; pregnant women and breast feeding mothers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of recovery of depression. Timepoint: before of study & follow up visits every a 2-weeksfor 8 weeks. Method of measurement: cheking of hamilton score.

Secondary

MeasureTime frame
Side effect of drugs. Timepoint: every 2 weeks for 8 weeks. Method of measurement: with history taking & blood pressure cheking.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.fariba amini

Shahid Sadughi University of Medical Science

f_amini_1974@yahoo.com ,f_amini_1974@gmail.com+98 38 1334 6898

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026